{{Rsnum
|rsid=7730843
|Chromosome=5
|position=36542210
|Orientation=plus
|GMAF=0.2521
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 2.7 | 26.5 | 70.8
| HCB | 1.5 | 14.6 | 83.9
| JPT | 0.0 | 13.3 | 86.7
| YRI | 44.2 | 44.9 | 10.9
| ASW | 33.3 | 45.6 | 21.1
| CHB | 1.5 | 14.6 | 83.9
| CHD | 1.8 | 14.7 | 83.5
| GIH | 1.0 | 18.8 | 80.2
| LWK | 42.7 | 42.7 | 14.5
| MEX | 1.7 | 29.3 | 69.0
| MKK | 16.7 | 48.7 | 34.6
| TSI | 2.0 | 30.4 | 67.6
| HapMapRevision=28
}}{{PharmGKB
|RSID=rs7730843
|Name_s=
|Gene_s=-
|Feature=
|Evidence=PubMed ID:18439552
|Annotation=In a GWAS of subjects from the PARC study (Pharmacogenomics and Risk of Cardiovascular Disease), this was one of the ten SNPs most strongly associated with plasma C-reactive protein levels.
|Drugs=
|Drug Classes=
|Diseases=Cardiovascular Diseases
|Curation Level=Curated
|PharmGKB Accession ID=PA162399735
}}

{{GET Evidence
|impact=pharmacogenetic
|qualified_impact=Insufficiently evaluated pharmacogenetic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs7730843
|overall_frequency_n=38
|overall_frequency_d=126
|overall_frequency=0.301587
|n_genomes=27
|n_genomes_annotated=0
|n_haplomes=35
|n_articles=1
|n_articles_annotated=0
|in_pharmgkb=Y
|autoscore=1
|webscore=N
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Illumina Human 1M}}